These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9608114)

  • 21. [Acute familial dystonia caused by antidopaminergic drugs].
    Hernández J; Arés A; Cantarero S; García Ruiz PJ
    Neurologia; 1999 Jan; 14(1):45. PubMed ID: 10079694
    [No Abstract]   [Full Text] [Related]  

  • 22. [Extrapyramidal adverse reactions to metoclopramide. A pharmacovigilance survey].
    Frez C; Awad Y; Sánchez N; Silva A; Mercado B; Marcotti C; Arévalo P; Apablaza K; Fernández P; Pérez D
    Rev Med Chil; 2018 Jul; 146(7):876-884. PubMed ID: 30534887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metoclopramide induced acute dystonic reaction: a case report.
    Tianyi FL; Agbor VN; Njim T
    BMC Res Notes; 2017 Jan; 10(1):32. PubMed ID: 28061898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute dystonic reaction to metoclopramide in patients carrying homozygous cytochrome P450 2D6 genetic polymorphisms.
    van der Padt A; van Schaik RH; Sonneveld P
    Neth J Med; 2006 May; 64(5):160-2. PubMed ID: 16702617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis.
    Patterson D; Abell T; Rothstein R; Koch K; Barnett J
    Am J Gastroenterol; 1999 May; 94(5):1230-4. PubMed ID: 10235199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metoclopramide versus ondansetron for the treatment of vomiting in children with acute gastroenteritis.
    Al-Ansari K; Alomary S; Abdulateef H; Alshawagfa M; Kamal K
    J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):156-60. PubMed ID: 21788756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute chorea associated with metoclopramide use.
    Dubow JS; Leikin J; Rezak M
    Am J Ther; 2006; 13(6):543-4. PubMed ID: 17122536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metoclopramide-induced impotence and akathisia: a case report.
    Tsai SJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jun; 57(6):443-6. PubMed ID: 8803308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study.
    Berkovitch M; Mazzota P; Greenberg R; Elbirt D; Addis A; Schuler-Faccini L; Merlob P; Arnon J; Stahl B; Magee L; Moretti M; Ornoy A
    Am J Perinatol; 2002 Aug; 19(6):311-6. PubMed ID: 12357422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind comparison of clebopride and placebo in dyspepsia secondary to delayed gastric emptying.
    Bavestrello L; Caimi L; Barbera A
    Clin Ther; 1985; 7(4):468-73. PubMed ID: 3893703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute oculogyric crisis in a patient taking clebopride.
    Kim W; Lee KS; Kim YI; Kim JS
    Intern Med; 2008; 47(6):551-2. PubMed ID: 18344644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of clebopride on lower esophageal sphincter pressure.
    Ribeiro V; da Silva AL; Castro Lde P
    Arq Gastroenterol; 1981; 18(2):71-4. PubMed ID: 7332503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metoclopramide-induced respiratory dyskinesia].
    Vorre MM; Lange P
    Ugeskr Laeger; 2019 Apr; 181(17):. PubMed ID: 31036138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of Adverse Events Associated with Domperidone and Metoclopramide in Gastroparesis: Systematic Review and Meta-analysis.
    Junqueira DR; Bennett D; Huh SY; Fahrbach K; Neupane B; Betts M
    Drugs R D; 2023 Mar; 23(1):1-20. PubMed ID: 36749528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishing a comprehensive questionnaire for detecting drug-induced extrapyramidal symptoms.
    Ohno K; Miyazawa S; Hashiguchi M; Unemoto T; Itoh A; Echizen H; Rikihisa T; Ogata H; Murata M
    Yakugaku Zasshi; 2003 Oct; 123(10):881-6. PubMed ID: 14577334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An estimate of the risk of movement disorders associated with the chronic use of clebopride.
    Sempere AP; Duarte J; García F; Cabezas C; Coria F; Clavería LE
    Mov Disord; 1996 Sep; 11(5):582-3. PubMed ID: 8866504
    [No Abstract]   [Full Text] [Related]  

  • 37. Varied Clinical Presentations of Acute Dystonic Reaction Due to Metoclopramide.
    El Ç; Çelikkaya ME
    Pediatr Emerg Care; 2019 May; 35(5):369-372. PubMed ID: 30908432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive supranuclear palsy syndrome induced by clebopride.
    Campdelacreu J; Kumru H; Tolosa E; Valls-Solé J; Benabarre A
    Mov Disord; 2004 Apr; 19(4):482-4. PubMed ID: 15077251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study of antiemetic properties of clebopride and metoclopramide in vomiting produced by cis-platinum (author's transl)].
    Padrón F; Sanz J; Flórez J
    Med Clin (Barc); 1981 Sep; 77(4):167-70. PubMed ID: 7031384
    [No Abstract]   [Full Text] [Related]  

  • 40. Abdominal pain with rigidity secondary to the anti-emetic drug metoclopramide.
    Khan NU; Razzak JA
    J Emerg Med; 2006 May; 30(4):411-3. PubMed ID: 16740451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.